“It’s a small cap, a billion-dollar company, 100% revenue growth, and it’s small and it’s unknown,” says the author of today’s article of the pharmaceutical marketing company he highlights, which is disrupting the way that drugs are traditionally sold to physicians – and has become a multi-bagger stock in the process. For more on this “under-the-radar pic for investors who…have…
“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” declares the author of today’s article of the five Buy-rated stocks trading under $10 that he highlights. Among them are a late-stage pharmaceutical company focused on developing potential new therapies for cancer, a security technology company that provides email encryption…
With their shares having surged by more than 484%, 500% and 275%, respectively, the three stocks highlighted in today’s article are three of the best-performing pharmaceutical stocks over the past year – and despite them having already experienced monster moves higher, it may not be too late to get in on these stocks’ gains. For more on these three pharmaceutical…